Abstract

Harnessing the unprecedented flexibility that iPSC technology and gene editing offer academic and industry-based researchers requires developing an interactive model of collaboration. Such a model will have to leverage the basic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and high throughput technology to be successful.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.